36 related articles for article (PubMed ID: 6921201)
1. Low-molecular weight inhibitors of the alternative complement pathway.
Schubart A; Flohr S; Junt T; Eder J
Immunol Rev; 2023 Jan; 313(1):339-357. PubMed ID: 36217774
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.
Schubart A; Anderson K; Mainolfi N; Sellner H; Ehara T; Adams CM; Mac Sweeney A; Liao SM; Crowley M; Littlewood-Evans A; Sarret S; Wieczorek G; Perrot L; Dubost V; Flandre T; Zhang Y; Smith RJH; Risitano AM; Karki RG; Zhang C; Valeur E; Sirockin F; Gerhartz B; Erbel P; Hughes N; Smith TM; Cumin F; Argikar UA; Haraldsson B; Mogi M; Sedrani R; Wiesmann C; Jaffee B; Maibaum J; Flohr S; Harrison R; Eder J
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7926-7931. PubMed ID: 30926668
[TBL] [Abstract][Full Text] [Related]
3. Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.
Janssen BJ; Gomes L; Koning RI; Svergun DI; Koster AJ; Fritzinger DC; Vogel CW; Gros P
EMBO J; 2009 Aug; 28(16):2469-78. PubMed ID: 19574954
[TBL] [Abstract][Full Text] [Related]
4. Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants.
Figueira MA; Ram S; Goldstein R; Hood DW; Moxon ER; Pelton SI
Infect Immun; 2007 Jan; 75(1):325-33. PubMed ID: 17088344
[TBL] [Abstract][Full Text] [Related]
5. Complement activation in factor D-deficient mice.
Xu Y; Ma M; Ippolito GC; Schroeder HW; Carroll MC; Volanakis JE
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14577-82. PubMed ID: 11724962
[TBL] [Abstract][Full Text] [Related]
6. New structural motifs on the chymotrypsin fold and their potential roles in complement factor B.
Jing H; Xu Y; Carson M; Moore D; Macon KJ; Volanakis JE; Narayana SV
EMBO J; 2000 Jan; 19(2):164-73. PubMed ID: 10637221
[TBL] [Abstract][Full Text] [Related]
7. MHC Class III products: an electron microscopic study of the C3 convertases of human complement.
Smith CA; Vogel CW; Müller-Eberhard HJ
J Exp Med; 1984 Jan; 159(1):324-9. PubMed ID: 6559206
[TBL] [Abstract][Full Text] [Related]
8. The membrane attack complex.
Müller-Eberhard HJ
Springer Semin Immunopathol; 1984; 7(2-3):93-141. PubMed ID: 6387983
[No Abstract] [Full Text] [Related]
9. The alternative pathway of complement.
Pangburn MK; Müller-Eberhard HJ
Springer Semin Immunopathol; 1984; 7(2-3):163-92. PubMed ID: 6238433
[No Abstract] [Full Text] [Related]
10. Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b.
Dahlbäck B; Smith CA; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3461-5. PubMed ID: 6222381
[TBL] [Abstract][Full Text] [Related]
11. The principal site of glycation of human complement factor B.
Niemann MA; Bhown AS; Miller EJ
Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):473-80. PubMed ID: 2006911
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of recombinant cobra venom factor.
Kock MA; Hew BE; Bammert H; Fritzinger DC; Vogel CW
J Biol Chem; 2004 Jul; 279(29):30836-43. PubMed ID: 15131128
[TBL] [Abstract][Full Text] [Related]
13. Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability.
Hew BE; Pangburn MK; Vogel CW; Fritzinger DC
Toxicon; 2020 Sep; 184():68-77. PubMed ID: 32526239
[TBL] [Abstract][Full Text] [Related]
14. Recombinant cobra venom factor.
Vogel CW; Fritzinger DC; Hew BE; Thorne M; Bammert H
Mol Immunol; 2004 Jun; 41(2-3):191-9. PubMed ID: 15159065
[TBL] [Abstract][Full Text] [Related]
15. Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion.
Vogel CW; Fritzinger DC
Curr Pharm Des; 2007; 13(28):2916-26. PubMed ID: 17979736
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement.
Smith CA; Vogel CW; Müller-Eberhard HJ
J Biol Chem; 1982 Sep; 257(17):9879-82. PubMed ID: 6921201
[TBL] [Abstract][Full Text] [Related]
17. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
